In the recent preso, the company said the phase 1 trial would start in Q2 this year (so Mar-Jun timeline).
But, I think someone mentioned here the trial was pushed back until this time next year?
Can anyone elaborate?
Cheers
Ann: Positive Preclincal Data on Efficacy in New Indication, page-8
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.06M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.0¢ | 74.3¢ | $107.9K | 143.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6522 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 11047 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |